Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applications for the DPhil in Medical Sciences for entry in October 2022 are now open. Further research opportunities may be added to this list over the next few weeks.

Chakraverty Group - Immunotherapy Ronjon Chakraverty
Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery Charalambos Antoniades
Bhattacharya Group - Therapeutic targeting of chemokines in inflammation Shoumo Bhattacharya
Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models Gillian Douglas
Choudhury Group - Innate immune function in atherosclerosis and acute myocardial infarction Robin Choudhury
Karpe Group - Human fat distribution and metabolic disease Fredrik Karpe
Kerr-Cai Group - Epigenetic regulation of cholangiocarcinoma growth David Kerr
Leeson Group - Imaging in Preventive Cardiology Research Paul Leeson
Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease Craig Lygate
Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques Stefan Piechnik
Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Svetlana Reilly
Tzima Group - Go with the flow---the why and how of cardiovascular disease Ellie Tzima
Watkins Group – Genetics of inherited cardiovascular disease Hugh Watkins
Drakesmith Group - Iron Biology Hal Drakesmith
Goriely Group - De Novo Mutations and Human Disease Anne Goriely
Higgs Group - Laboratory of Gene Regulation Douglas Higgs
Mead Group - Unravelling mechanisms of disease progression in Myeloproliferative Neoplasms Adam Mead
Vyas Group - Normal and leukaemic stem/progenitor cell biology and immune responses to blood cancer cells. Paresh Vyas
Wilkie Group - Building the skull – normal and abnormal development Andrew Wilkie
Nerlov Group - Hematopoietic Stem Cell Genetics Claus Nerlov
Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells KJ Patel
Rorsman Group - Preferential Gq signalling in diabetes: an electrical switch in incretin action and in diabetes progression? Patrik Rorsman
Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. Christopher Toepfer
Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. Constantinos Christodoulides
Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Simon Davis
Chapman Group - Genome Diversification in Cancer and Adaptive Immunity Ross Chapman
David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues
Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Ladislav Valkovic